Efficacy of Tocilizumab in Refractory Graves Orbitopathy From Real-World Clinical Practice: An Observational Study
2024

Effectiveness of Tocilizumab for Graves Orbitopathy

Sample size: 79 publication Evidence: high

Author Information

Author(s): Wang Mingyang, Qin Bixuan, Liu Cuihong, Liu Honglei, Li Dongmei

Primary Institution: Beijing Tongren Hospital, Capital Medical University

Hypothesis

The study aims to evaluate the effectiveness of tocilizumab in treating Graves orbitopathy that is resistant to conventional therapy.

Conclusion

Tocilizumab is a valuable treatment option for patients with active, corticosteroid-resistant Graves orbitopathy.

Supporting Evidence

  • Significant improvements were found in visual acuity, intraocular pressure, proptosis, clinical activity score, and TRAb levels.
  • 71.4% of adults and 60% of pediatric patients experienced a decrease in clinical activity score by at least 2 points.
  • 89.3% of adults and 60% of pediatric patients achieved low activity disease status after treatment.

Takeaway

This study shows that a medicine called tocilizumab can help people with a serious eye problem caused by thyroid disease, especially when other treatments don't work.

Methodology

This observational study included 79 patients with Graves orbitopathy, treated with tocilizumab every 28 days for 4 months, assessing various ocular parameters and clinical activity scores.

Potential Biases

The study design may have inherent biases due to its observational nature and the lack of a control group.

Limitations

The study had a small number of pediatric patients and could not determine recurrence rates after discontinuation of tocilizumab.

Participant Demographics

79 Chinese patients, including 15 pediatric patients, with a mean age of 39.87 years; 65.8% were female.

Statistical Information

P-Value

p<0.05

Confidence Interval

0.003∼0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1210/jendso/bvae193

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication